Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

ABSTRACT

BACKGROUND

Chronic hepatitis C virus (HCV) infection is more prevalent among patients who have chronic kidney disease than among those who do not have the disease. Patients with chronic kidney disease who also have HCV infection are at higher risk for progression to end-stage renal dis...